A novel dual PPAR- γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes

Conclusions/interpretationThese findings demonstrate that a novel sHE inhibitor/PPAR- γ agonist molecule targets multiple risk factors of the metabolic syndrome and is a glucose-lowering agent with a strong ability to treat diabetic complications.

Source: Diabetologia - August 31, 2018 Category: Endocrinology Source Type: research